View Clinical Trial (Medical Research Study)


An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia - NCT01175135-60169(Clinical Trial 786685)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City: Hoffman Estates
State: IL
Zip Code: 60169
Country: United States
Purpose: This study aims to evaluate whether PF-02545920 is safe and effective in the treatment of acute exacerbation of schizophrenia during a 4-week inpatient treatment period. The study will use the Positive and Negative Syndrome Scale (PANSS) to measure change in symptoms for PF-02545920 compared to risperidone and placebo treatment.
This page is no longer being updated. Please use our search for current trials or visit ClinicalTrials.gov
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.